Meta-analysis of Published Efficacy and Safety Data for Docetaxel in Second-Line Treatment of Patients with Advanced Non-Small-cell Lung Cancer
Cancer chemotherapy and pharmacology(2016)
Abstract
To gain a better understanding of the impact of dose and other prognostic factors on safety and efficacy of docetaxel in second-line non-small-cell lung cancer patients.
MoreTranslated text
Key words
Model-based meta-analysis,Docetaxel,Non‐small‐cell lung cancer,Dose–response
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined